181 related articles for article (PubMed ID: 26817957)
1. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Ihaddadene R; Corsi DJ; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Le Gal G; Carrier M
Blood; 2016 Apr; 127(16):2035-7. PubMed ID: 26817957
[TBL] [Abstract][Full Text] [Related]
2. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
3. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
Robin P; Otten HM; Delluc A; van Es N; Carrier M; Salaün PY; Le Gal G
Thromb Res; 2018 Nov; 171():92-96. PubMed ID: 30268858
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism and occult cancer: impact on clinical practice.
Gheshmy A; Carrier M
Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
[TBL] [Abstract][Full Text] [Related]
5. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
6. Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future.
van Es N; Ay C; Jara-Palomares L
Hamostaseologie; 2020 Aug; 40(3):270-279. PubMed ID: 32726822
[TBL] [Abstract][Full Text] [Related]
7. Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
Carrier M; Lazo-Langner A; Shivakumar S; Tagalakis V; Zarychanski R; Solymoss S; Routhier N; Douketis J; Danovitch K; Lee AY; Le Gal G; Wells PS; Corsi DJ; Ramsay T; Coyle D; Chagnon I; Kassam Z; Tao H; Rodger MA;
N Engl J Med; 2015 Aug; 373(8):697-704. PubMed ID: 26095467
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Tromeur C; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Nov; 159():48-51. PubMed ID: 28978463
[TBL] [Abstract][Full Text] [Related]
9. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
[TBL] [Abstract][Full Text] [Related]
10. A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism.
Rosell A; Lundström S; Mackman N; Wallén H; Thålin C
J Thromb Thrombolysis; 2019 Jul; 48(1):111-118. PubMed ID: 30739306
[TBL] [Abstract][Full Text] [Related]
11. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
[TBL] [Abstract][Full Text] [Related]
12. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Carrier M
Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
[TBL] [Abstract][Full Text] [Related]
13. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
[No Abstract] [Full Text] [Related]
14. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
15. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
[TBL] [Abstract][Full Text] [Related]
16. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.
Jara-Palomares L; Otero R; Jimenez D; Praena-Fernandez JM; Font C; Falga C; Soler S; Riesco D; Verhamme P; Monreal M;
PLoS One; 2018; 13(3):e0194673. PubMed ID: 29558509
[TBL] [Abstract][Full Text] [Related]
17. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
[TBL] [Abstract][Full Text] [Related]
18. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
[TBL] [Abstract][Full Text] [Related]
19. Utility of additional abdominopelvic CT in detecting occult cancer in patients with unprovoked venous thromboembolism.
Vaidyanathan S; Walsh J; Cliffe H; Saleem N; Weston MJ; Lowe AS; Chowdhury FU
Clin Radiol; 2016 Jun; 71(6):501-6. PubMed ID: 27005017
[TBL] [Abstract][Full Text] [Related]
20. [Screening for occult cancer in patients with unprovoked venous thromboembolism].
Qiao LS; Xu XM
Zhonghua Jie He He Hu Xi Za Zhi; 2023 May; 46(5):498-502. PubMed ID: 37147813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
